Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:insulin |
| gptkbp:administeredBy |
subcutaneous injection
|
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States gptkb:FDA 2004 |
| gptkbp:ATCCode |
A10AB06
|
| gptkbp:availableOn |
cartridge
pre-filled pen vial |
| gptkbp:chemicalClass |
gptkb:insulin
|
| gptkbp:duration |
short
|
| gptkbp:form |
gptkb:government_agency
|
| gptkbp:halfLife |
short
|
| https://www.w3.org/2000/01/rdf-schema#label |
Apidra
|
| gptkbp:indication |
gptkb:type_2_diabetes
type 1 diabetes |
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:mechanismOfAction |
lowers blood glucose
|
| gptkbp:onset |
gptkb:fire
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
injection
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
injection site reaction allergic reaction |
| gptkbp:usedFor |
gptkb:diabetes_mellitus
|
| gptkbp:bfsParent |
gptkb:insulin
gptkb:赛诺菲 |
| gptkbp:bfsLayer |
6
|